hookworm vaccine

hookworm vaccine

An obsolete vaccine prepared from irradiated hookworms, formerly used to protect dogs from Ancylostoma caninum.
References in periodicals archive ?
Epidemiological, immunological and practical consideration in developing and evaluating a human hookworm vaccine.
1 million to researchers at The George Washington University School of Medicine and Health Sciences for a stage 1 trial reviewing hookworm vaccine in an outbreak region in Brazil.
The topics include harnessing genomic technologies to explore the molecular biology of liver flukes, identifying and profiling nematicidal compounds in veterinary parasitology, drugs and targets to perturb the symbiosis of Wolbachia and filarial nematodes, the preclinical development of a human hookworm vaccine, new approaches to antigen discovery and promising new candidates for schistosomiasis vaccines, and vaccines against cestode parasites.
M2 PHARMA-February 1, 2012-IDRI provides support to human hookworm vaccine trial(C)2012 M2 COMMUNICATIONS
Hotez disclosed that he has a patent on a hookworm vaccine, but no relationships with pharmaceutical companies.
Hotez PJ, Ghosh K, Hawdon JM, Narasimhan S, Jones B, Xiao SH, et alExperimental approaches to the development of a recombinant hookworm vaccine.
Until new approaches become available, whether a hookworm vaccine or improved sanitation infrastructures, deworming for school-age children remains the most practical way to control helminth infections in the developing world.
Barefoot thru' the Valley of Darkness: Preclinical development of a human hookworm vaccine
The expression of this antigen represents a major breakthrough in the development of a human hookworm vaccine.
Hotez, President and CEO of the Sabin Vaccine Institute, Director of the Human Hookworm Vaccine Initiative and the Global Network for Neglected Tropical Disease Control and Walter G.
They include: the Sabin Vaccine Institute's Human Hookworm Vaccine Initiative; Schistosomiasis Control Initiative, Imperial College of London; International Trachoma Initiative; Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine; The Task Force for Child Survival and Development; Helen Keller International and The Earth Institute, Columbia University.
This will serve as an important platform to help bring critical topics including the GNNTDC mission and Human Hookworm Vaccine Initiative to the forefront of the global health conversation.